Effects of an intensive lifestyle intervention and the role of sleep in people living with HIV and prediabetes: a pilot and feasibility study
- PMID: 33865450
- PMCID: PMC8052817
- DOI: 10.1186/s13104-021-05558-z
Effects of an intensive lifestyle intervention and the role of sleep in people living with HIV and prediabetes: a pilot and feasibility study
Abstract
Objectives: Prediabetes is prevalent in people living with HIV (PLWH). Insufficient and irregular sleep are linked to abnormal glucose metabolism. This study aimed to investigate the differences in sleep characteristics between PLWH with and without prediabetes, determine the acceptability/feasibility and effects of a pilot six-month intensive lifestyle intervention (ILI) program on glucose metabolism in those with prediabetes, and determine how sleep modulates these effects.
Results: Thirty-nine PLWH (20 normoglycemia and 19 prediabetes) participated. There were no differences in sleep characteristics between individuals with normoglycemia and prediabetes. Next, thirteen individuals with prediabetes completed a six-month ILI program. The ILI program resulted in significant body weight reduction at 6 months (63.5 ± 13.9 to 61.9 ± 14.0 kg, p = 0.012), which was maintained at 12 months (p < 0.001). Waist circumferences were significantly decreased at 12 months (85.4 ± 11.7 to 82.9 ± 12.7 cm, p = 0.014). An increase in sleep variability was significantly associated with an increase in 2-h plasma glucose, independent of changes in BMI (b = 0.603), and physical activity (b = 0.774). This pilot study suggested that ILI in PLWH with prediabetes is feasible and effective in improving metabolic control, with its effects possibly modulated by sleep variability. These findings should be confirmed in a larger study to reduce diabetes risk in this population. Trail registration: ClinicalTrial.gov, NCT03545217 (date of registration: May 22, 2018).
Keywords: HIV; Intensive lifestyle intervention; Prediabetes; Sleep.
Conflict of interest statement
HN received speaker honoraria from Novo Nordisk, Takeda, MSD, Sanofi Aventis, Amgen, Eli lily, Boehringer Ingelheim Pharmaceuticals and Novartis. SR received speaker honoraria from Novo Nordisk, Sanofi Aventis and Medtronic; a research grant from Merck Sharp and Dohme; and non-financial support from ResMed, Thailand
Similar articles
-
Effective Translation of an Intensive Lifestyle Intervention for Hispanic Women With Prediabetes in a Community Health Center Setting.Diabetes Care. 2016 Apr;39(4):525-31. doi: 10.2337/dc15-1899. Epub 2016 Feb 23. Diabetes Care. 2016. PMID: 26908915 Free PMC article. Clinical Trial.
-
The effectiveness of a primary care nursing-led dietary intervention for prediabetes: a mixed methods pilot study.BMC Fam Pract. 2017 Dec 21;18(1):106. doi: 10.1186/s12875-017-0671-8. BMC Fam Pract. 2017. PMID: 29268719 Free PMC article. Clinical Trial.
-
Efficacy of lifestyle interventions in the reversion to normoglycemia in Korean prediabetics: One-year results from a randomised controlled trial.Prim Care Diabetes. 2019 Jun;13(3):212-220. doi: 10.1016/j.pcd.2018.11.017. Epub 2018 Dec 21. Prim Care Diabetes. 2019. PMID: 30583933 Clinical Trial.
-
Prediabetes: the importance of early identification and intervention.Postgrad Med. 2010 Jul;122(4):129-43. doi: 10.3810/pgm.2010.07.2180. Postgrad Med. 2010. PMID: 20675976 Review.
-
[Treatment of hypertension associated with prediabetes].Orv Hetil. 2009 May 17;150(20):917-23. doi: 10.1556/OH.2009.28619. Orv Hetil. 2009. PMID: 19423489 Review. Hungarian.
Cited by
-
Sleep deficiency among people living with human immunodeficiency virus: A growing challenge.HIV Med. 2024 Jan;25(1):5-15. doi: 10.1111/hiv.13526. Epub 2023 Jul 23. HIV Med. 2024. PMID: 37485570 Free PMC article. Review.
-
Awareness and perceived risk of type 2 diabetes among older adults with HIV: results from a qualitative study.AIDS Care. 2025 Jul;37(7):1160-1166. doi: 10.1080/09540121.2025.2474667. Epub 2025 Mar 11. AIDS Care. 2025. PMID: 40066520 Free PMC article.
References
-
- Tripathi A, Jerrell JM, Liese AD, Zhang J, Rizvi AA, Albrecht H, et al. Association of clinical and therapeutic factors with incident dyslipidemia in a cohort of human immunodeficiency virus-infected and non-infected adults: 1994–2011. Metab Syndr Relat Disord. 2013;11(6):417–426. doi: 10.1089/met.2013.0017. - DOI - PubMed
-
- Tripathi A, Liese AD, Jerrell JM, Zhang J, Rizvi AA, Albrecht H, et al. Incidence of diabetes mellitus in a population-based cohort of HIV-infected and non-HIV-infected persons: the impact of clinical and therapeutic factors over time. Diabet Med. 2014;31(10):1185–1193. doi: 10.1111/dme.12455. - DOI - PubMed
-
- Chantrathamachart P, Sungkanuparph S, Kiertburanakul S, Malathum K. Diabetes mellitus and hypertension in hiv-infected patients receiving antiretrovial therapy: a pilot study. J Infect Dis Antimicrob Agent. 2006;22:131.
-
- Aekplakorn W, Chariyalertsak S, Kessomboon P, Sangthong R, Inthawong R, Putwatana P, et al. Prevalence and management of diabetes and metabolic risk factors in Thai adults: the Thai National Health Examination Survey IV, 2009. Diabetes Care. 2011;34(9):1980–1985. doi: 10.2337/dc11-0099. - DOI - PMC - PubMed
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical